Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

30 56 30 30 13 4 7 15 13 20 25 12 35 13 2

Research, Review articles and Editorials

0 6 2 4 1 1 6 14 12 17 25 12 34 7 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

30 50 28 8 2 0 1 1 1 2 0 0 0 0 0

Conference proceedings

0 0 0 0 0 0 35 102 83 47 82 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

35 55 58 71 61 49 63 48 72 63 23 8 6 0 0
Journal total citations count 613
Journal impact factor 2.31
Journal 5 years impact factor 3.74
Journal cite score 4.86
Journal h-index 12
Important citations

Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases

Frequencies of functional polymorphisms in three pharmacokinetic genes of clinical interest within the admixed Puerto Rican population

Pharmacogenetics of drug-metabolizing enzymes in US Hispanics

A comprehensive survey of models for dissecting local ancestry deconvolution in human genome

Pharmacogenetically driven treatments for alcoholism

A novel admixture-based pharmacogenetic approach to refine warfarin dosing in Caribbean Hispanics

 Impacto da farmacogenética na farmacocinética dos antirretrovíricos em doentes coinfetados por vírus da imunodeficiência humana (VIH) e vírus da hepatite B (VHB) e/ou Vírus da hepatite C (VHC)

O papel da farmacogenética na terapia do HIV

Farmacogenómica aplicada ao tratamento antirretroviral em Portugal

Conjugar a farmacogenética ea monitorização terapêutica de fármacos: uma estratégia na otimização e individualização da farmacoterapia

Sistema HLA y factores farmacogenéticos en la evolución de la infección por VIH-1 en pacientes de Las Palmas de Gran Canaria

Pediatric Infectious Diseases

Investigation of Molecular Mechanisms Regulating Drug-Drug Interactions in Antiretroviral Therapy

Cytochrome P450 CYP2B6 983T> C Polymorphism as Predictor of Nevirapine Hypersensitivity in Botswana Population.

A pharmacist's role in the individualization of treatment of HIV patients

Adverse drug reactions associated with CYP 2B6 polymorphisms in HIV/AIDS-treated patients in Yaoundé, Cameroon

Genotype and allele frequencies of ABCB1 and SLCO1B1 polymorphisms in THAI HIV-infected patients

Important pharmacogenomic aspects in the management of HIV/AIDS

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients

Individualization of antiretroviral therapy-Pharmacogenomic aspect